Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease

Cardiovascular disease is the leading cause of the death in dialysis patients. Arteriovenous fistulas (AVFs) are associated with lower mortality and are viewed as the desired access option in most patients with advanced kidney disease needing dialysis. However, AVFs have significant and potentially deleterious effects on cardiac functions particularly in the setting of preexisting heart disease. This article provides a comprehensive and contemporary review to what is known about the impact of AVFs on: congestive heart failure, left ventricular hypertrophy, pulmonary hypertension, right ventricular dysfunction, coronary artery disease and valvular heart disease.

Saved in:
Bibliographic Details
Main Authors: Alkhouli,Mohamad, Sandhu,Paul, Boobes,Khlaed, Hatahet,Kamel, Raza,Farhan, Boobes,Yousef
Format: Digital revista
Language:English
Published: Sociedad Española de Nefrología 2015
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952015000300002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0211-69952015000300002
record_format ojs
spelling oai:scielo:S0211-699520150003000022015-09-15Cardiac complications of arteriovenous fistulas in patients with end-stage renal diseaseAlkhouli,MohamadSandhu,PaulBoobes,KhlaedHatahet,KamelRaza,FarhanBoobes,Yousef Hemodialysis vascular access Cardiovascular Fistula Kidney transplantation Cardiovascular disease is the leading cause of the death in dialysis patients. Arteriovenous fistulas (AVFs) are associated with lower mortality and are viewed as the desired access option in most patients with advanced kidney disease needing dialysis. However, AVFs have significant and potentially deleterious effects on cardiac functions particularly in the setting of preexisting heart disease. This article provides a comprehensive and contemporary review to what is known about the impact of AVFs on: congestive heart failure, left ventricular hypertrophy, pulmonary hypertension, right ventricular dysfunction, coronary artery disease and valvular heart disease.Sociedad Española de NefrologíaNefrología (Madrid) v.35 n.3 20152015-01-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952015000300002en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Alkhouli,Mohamad
Sandhu,Paul
Boobes,Khlaed
Hatahet,Kamel
Raza,Farhan
Boobes,Yousef
spellingShingle Alkhouli,Mohamad
Sandhu,Paul
Boobes,Khlaed
Hatahet,Kamel
Raza,Farhan
Boobes,Yousef
Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
author_facet Alkhouli,Mohamad
Sandhu,Paul
Boobes,Khlaed
Hatahet,Kamel
Raza,Farhan
Boobes,Yousef
author_sort Alkhouli,Mohamad
title Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
title_short Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
title_full Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
title_fullStr Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
title_full_unstemmed Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
title_sort cardiac complications of arteriovenous fistulas in patients with end-stage renal disease
description Cardiovascular disease is the leading cause of the death in dialysis patients. Arteriovenous fistulas (AVFs) are associated with lower mortality and are viewed as the desired access option in most patients with advanced kidney disease needing dialysis. However, AVFs have significant and potentially deleterious effects on cardiac functions particularly in the setting of preexisting heart disease. This article provides a comprehensive and contemporary review to what is known about the impact of AVFs on: congestive heart failure, left ventricular hypertrophy, pulmonary hypertension, right ventricular dysfunction, coronary artery disease and valvular heart disease.
publisher Sociedad Española de Nefrología
publishDate 2015
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952015000300002
work_keys_str_mv AT alkhoulimohamad cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
AT sandhupaul cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
AT boobeskhlaed cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
AT hatahetkamel cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
AT razafarhan cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
AT boobesyousef cardiaccomplicationsofarteriovenousfistulasinpatientswithendstagerenaldisease
_version_ 1755936405132935168